MTOR and nonpapillary renal cell carcinoma: In summary, the present study detected the expression of mTOR and p-mTOR in ccRCC patients using WB analysis, investigated their prognosis using IHC assay, and explored the interactions between mTOR and immune infiltrates using TIMER and TISIDB databases, which aimed to elucidate the clinical significance of mTOR in ccRCC.